Acrivon Therapeutics Inc.... (ACRV)
NASDAQ: ACRV
· Real-Time Price · USD
1.21
-0.01 (-0.82%)
At close: Jun 17, 2025, 3:59 PM
1.21
0.41%
After-hours: Jun 17, 2025, 05:55 PM EDT
-0.82% (1D)
| Bid | 1.16 |
| Market Cap | 37.78M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -83.75M |
| EPS (ttm) | -2.16 |
| PE Ratio (ttm) | -0.56 |
| Forward PE | -0.52 |
| Analyst | Buy |
| Ask | 1.3 |
| Volume | 217,524 |
| Avg. Volume (20D) | 781,249 |
| Open | 1.22 |
| Previous Close | 1.22 |
| Day's Range | 1.18 - 1.24 |
| 52-Week Range | 1.05 - 10.16 |
| Beta | 1.56 |
About ACRV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACRV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACRV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-17.59%
ACRV stock has given up its prior gain. Acrivion T...
Unlock content with
Pro Subscription
1 month ago
-17.59%
Acrivion Therapeutics shares are trading higher after the company announced it will present data from its analysis of ACR-2316.
